About University of Rochester Medical Center - Vaccine Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Rochester Medical Center - Vaccine Research Unit
During the past decade, University of Rochester Medical Center - Vaccine Research Unit conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rochester Medical Center - Vaccine Research Unit"
#1 collaborator was "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Rochester Medical Center - Vaccine Research Unit
According to Clinical.Site data, the most researched conditions in "University of Rochester Medical Center - Vaccine Research Unit" are
"COVID-19" (6 trials), "2009 H1N1 Influenza Virus" (1 trials), "Avian Influenza" (1 trials) and "Immunisation" (1 trials). Many other conditions were trialed in "University of Rochester Medical Center - Vaccine Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at University of Rochester Medical Center - Vaccine Research Unit
Most popular intervention types in "University of Rochester Medical Center - Vaccine Research Unit" are "Drug" (6 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Remdesivir" (4 trials), "BNT162b2" (2 trials), "Baricitinib" (2 trials) and "mRNA-1273" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University of Rochester Medical Center - Vaccine Research Unit
The vast majority of trials in "University of Rochester Medical Center - Vaccine Research Unit" are
8 trials for "All" genders.
Clinical Trials Status at University of Rochester Medical Center - Vaccine Research Unit
Currently, there are NaN active trials in "University of Rochester Medical Center - Vaccine Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in University of Rochester Medical Center - Vaccine Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Rochester Medical Center - Vaccine Research Unit, 4 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".